Skip to main content

Rothblatt Martine A's Form 4 filing

United Therapeutics Corp (UTHR) · filed Apr 23, 2024

Accession no.
0001415889-24-011370
Filed
Apr 23, 2024
Trade date
Apr 19-22, 2024
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 10 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.70M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Rothblatt Martine ACIK 0001106578Director, Officer (CHAIRPERSON & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 19, 2024Common StockMOption exerciseAcquired+3,600$129.49+$466,1643,730Direct
Apr 19, 2024Common StockSSaleDisposed−486$235.96F2−$114,676.563,244Direct
Apr 19, 2024Common StockSSaleDisposed−2,803$236.97F3−$664,226.91441Direct
Apr 19, 2024Common StockSSaleDisposed−311$237.88F4−$73,980.68130Direct
Apr 22, 2024Common StockMOption exerciseAcquired+3,600$129.49+$466,1643,730Direct
Apr 22, 2024Common StockSSaleDisposed−266$234.56F5−$62,392.963,464Direct
Apr 22, 2024Common StockSSaleDisposed−1,589$235.75F6−$374,606.751,875Direct
Apr 22, 2024Common StockSSaleDisposed−719$236.76F7−$170,230.441,156Direct
Apr 22, 2024Common StockSSaleDisposed−882$237.79F8−$209,730.78274Direct
Apr 22, 2024Common StockSSaleDisposed−144$238.36F9−$34,323.84130Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 19, 2024Common StockMOption exerciseDisposed−3,600$0.00$0313,469Direct
Apr 22, 2024Common StockMOption exerciseDisposed−3,600$0.00$0309,869Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $235.45 to $236.425. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F3

This transaction was executed in multiple trades at prices ranging from $236.47 to $237.425. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $237.47 to $238.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F5

This transaction was executed in multiple trades at prices ranging from $233.91 to $234.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F6

This transaction was executed in multiple trades at prices ranging from $235.21 to $236.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F7

This transaction was executed in multiple trades at prices ranging from $236.21 to $237.185. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F8

This transaction was executed in multiple trades at prices ranging from $237.31 to $238.305. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F9

This transaction was executed in multiple trades at prices ranging from $238.31 to $238.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)